5-74685474-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000521.4(HEXB):​c.214C>T​(p.Leu72Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,611,790 control chromosomes in the GnomAD database, including 113 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L72L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0076 ( 4 hom., cov: 30)
Exomes 𝑓: 0.010 ( 109 hom. )

Consequence

HEXB
NM_000521.4 missense

Scores

6
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.330
Variant links:
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005268872).
BP6
Variant 5-74685474-C-T is Benign according to our data. Variant chr5-74685474-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 129224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-74685474-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00763 (1160/151966) while in subpopulation NFE AF= 0.0104 (706/67936). AF 95% confidence interval is 0.00976. There are 4 homozygotes in gnomad4. There are 554 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HEXBNM_000521.4 linkuse as main transcriptc.214C>T p.Leu72Phe missense_variant 1/14 ENST00000261416.12
HEXBNM_001292004.2 linkuse as main transcriptc.-376-3854C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HEXBENST00000261416.12 linkuse as main transcriptc.214C>T p.Leu72Phe missense_variant 1/141 NM_000521.4 P1
HEXBENST00000511181.5 linkuse as main transcriptc.-376-3854C>T intron_variant 1
HEXBENST00000513079.5 linkuse as main transcriptn.279C>T non_coding_transcript_exon_variant 1/62
HEXBENST00000515528.1 linkuse as main transcriptn.269C>T non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
AF:
0.00764
AC:
1160
AN:
151848
Hom.:
4
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00215
Gnomad AMI
AF:
0.0439
Gnomad AMR
AF:
0.00675
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.000974
Gnomad SAS
AF:
0.00945
Gnomad FIN
AF:
0.00943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0104
Gnomad OTH
AF:
0.00817
GnomAD3 exomes
AF:
0.00776
AC:
1903
AN:
245082
Hom.:
16
AF XY:
0.00791
AC XY:
1056
AN XY:
133488
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.00488
Gnomad ASJ exome
AF:
0.0142
Gnomad EAS exome
AF:
0.0000558
Gnomad SAS exome
AF:
0.00768
Gnomad FIN exome
AF:
0.00777
Gnomad NFE exome
AF:
0.0100
Gnomad OTH exome
AF:
0.0107
GnomAD4 exome
AF:
0.0103
AC:
15074
AN:
1459824
Hom.:
109
Cov.:
35
AF XY:
0.0102
AC XY:
7431
AN XY:
726230
show subpopulations
Gnomad4 AFR exome
AF:
0.00183
Gnomad4 AMR exome
AF:
0.00551
Gnomad4 ASJ exome
AF:
0.0125
Gnomad4 EAS exome
AF:
0.0000505
Gnomad4 SAS exome
AF:
0.00827
Gnomad4 FIN exome
AF:
0.00903
Gnomad4 NFE exome
AF:
0.0114
Gnomad4 OTH exome
AF:
0.00952
GnomAD4 genome
AF:
0.00763
AC:
1160
AN:
151966
Hom.:
4
Cov.:
30
AF XY:
0.00746
AC XY:
554
AN XY:
74266
show subpopulations
Gnomad4 AFR
AF:
0.00214
Gnomad4 AMR
AF:
0.00674
Gnomad4 ASJ
AF:
0.0156
Gnomad4 EAS
AF:
0.00117
Gnomad4 SAS
AF:
0.00946
Gnomad4 FIN
AF:
0.00943
Gnomad4 NFE
AF:
0.0104
Gnomad4 OTH
AF:
0.00808
Alfa
AF:
0.0100
Hom.:
16
Bravo
AF:
0.00738
TwinsUK
AF:
0.00998
AC:
37
ALSPAC
AF:
0.0145
AC:
56
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0112
AC:
96
ExAC
AF:
0.00745
AC:
904
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0106
EpiControl
AF:
0.00856

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 23, 2015- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2024HEXB: BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsFeb 17, 2016- -
Benign, criteria provided, single submitterclinical testingGeneDxApr 25, 2019- -
Sandhoff disease Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 04, 2019- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMay 01, 2017- -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 22, 2016- -
HEXB-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJul 15, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
16
DANN
Uncertain
0.99
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.018
N
MetaRNN
Benign
0.0053
T
MetaSVM
Uncertain
-0.12
T
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.31
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.053
T
Vest4
0.22
MVP
0.82
MPC
0.49
ClinPred
0.039
T
GERP RS
-0.56
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147155126; hg19: chr5-73981299; COSMIC: COSV54667854; API